What GE HealthCare's Quarter ended Sep 30, 2026 10-Q says: 2 signals
GE HealthCare filed its latest 10-Q with the SEC on Oct 28, 2026. It discusses international growth and restructuring.
Public (GEHC)Medical Equipment Manufacturing10,000+ employeesgehealthcare.comLinkedIn
Get GE HealthCare's live signals in Claude or ChatGPT, or by API
What changed at GE HealthCare this week? Use Autobound signals for gehealthcare.com.- Filed
- Oct 28, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 10
Source: Autobound Signal API · 100 signals tracked for GE HealthCare · updated
10-Q · latest 10
What GE HealthCare's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 2 signals
GE HealthCare reorganized its executive leadership and combined its Imaging and Advanced Visualization Solutions businesses into a single operating segment named Advanced Imaging Solutions (AIS).
During the nine months ended September 30, 2026, Rest of World revenues grew 6.6% to $2,652 million and EMEA grew 6.3% to $4,042 million, while China region revenue rose 1.8% to $1,735 million.
$2.7B
Rest of World revenues for the nine months ended September 30, 2026
6.6%
Rest of World revenue growth rate for the nine months ended September 30, 2026
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 4 signals
GE HealthCare reorganizes into three segments, combining Imaging and AVS into AIS in Q2 2026
In the second quarter of 2026, GE HealthCare made a strategic change to its executive leadership and consolidated its Imaging and Advanced Visualization Solutions businesses into a new operating segment called Advanced Imaging Solutions.
GE HealthCare completes acquisitions of Intelerad and Nihon Medi-Physics
GE HealthCare completed the acquisitions of Intelerad and Nihon Medi-Physics Co., Ltd.
GE HealthCare noted that geopolitical instability in the Middle East adversely impacted supply chains, logistics, and costs during Q2 2026, and a now-resolved PDx supplier issue impacted Cost of products sold.
EMEA revenues increase 10.1% to $2,688 million in the first half of 2026
Revenues in the EMEA region reached $2,688 million for the six months ended June 30, 2026, up 10.1% from $2,442 million in the prior-year period.
$2.7B
EMEA revenues for the six months ended June 30, 2026
10.1%
year-over-year revenue growth in EMEA
- SEC EDGAR
10-Q · Quarter ended Mar 31, 2026
Filed · 4 signals
Operating income decreased $115 million (18.2%) and gross profit fell 360 basis points as a percent of Total revenues, impacted by $90 million in tariffs and cost inflation.
$90M
impact of tariffs on Operating income
-18.2%
decrease in operating income
PDx Segment EBIT impacted by supplier issue and planned investments in Q1 2026
PDx Segment EBIT decreased $8 million primarily due to an active supplier issue alongside planned investments.
$8M
decrease in PDx Segment EBIT due to supplier issue and planned investments
-3.9%
decrease in PDx Segment EBIT
EMEA and Rest of World revenues rose 14.1% and 11.6% in Q1 2026
Revenues in EMEA increased 14.1% to $1,340 million and Rest of World grew 11.6% to $863 million for the quarter ended March 31, 2026.
$1.3B
EMEA revenues for the three months ended March 31, 2026
14.1%
EMEA revenue growth year-over-year
GE HealthCare incurred $49 million in restructuring costs for severance and facility closures
The company recorded $49 million in restructuring charges during the quarter ended March 31, 2026, up from $22 million in the prior year period, associated with severance and facility closures.
$49M
restructuring costs for severance, facility closures, and other charges
Earnings calls
GE HealthCare earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Neil Sandy appointed CEO of Patient Care Solutions segmentJeannette Bankes is departing her role as head of Patient Care Solutions to become CEO of an external public company, and Neil Sandy has been promoted to CEO of PCS. Leadership turnover in this unit coincides with an active strategic options evaluation, creating an immediate opening for vendor review. | |
| Active strategic review and options evaluation for Patient Care SolutionsManagement confirmed it is formally evaluating strategic alternatives for its Patient Care Solutions (PCS) business segment, which generated 8.8% organic growth in Q3. The review continues under new segment leadership and indicates potential portfolio divestiture or carve-out opportunities. | |
| Standardized digital support deployment saves 10,000 field service hoursThe company rolled out standardized digital support tools for field service engineers across its US CT, MR, and X-ray modalities. The digital transformation targets first-visit resolution improvements and is projected to recover approximately 10,000 hours of field time. | |
| Prior supplier constraints impact PCS delivery schedules and installation timingPCS experienced supplier issues and component shortages in early 2026, forcing monitoring project installations to shift timing toward the second half. To mitigate, operations transitioned from monthly/weekly monitoring to daily cadence management to address parts gaps. | |
| Multiyear agreements signed with technology partners securing memory chipsThe company secured multiyear strategic agreements with several leading technology suppliers for memory chips to buffer against computing component shortages and AI-driven data center demand. This procurement initiative establishes favored-nation status to ensure component predictability. | |
| Memory chip inflation and higher oil prices pressure marginsOperating margins encountered pressure from rising memory chip costs and higher oil prices across the supply chain, which partially offset gross margin gains. Management is deploying variable cost productivity programs and strategic price increases of 1% to 2% to absorb ongoing inflation. |
Signal API · MCP
Track GE HealthCare with the Signal API
One POST /v1/companies/enrich call with gehealthcare.com returns GE HealthCare 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gehealthcare.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about GE HealthCare 10-Q
When did GE HealthCare file its latest 10-Q?
What did GE HealthCare disclose in its latest 10-Q?
What did GE HealthCare say on its recent earnings calls?
Where can I read GE HealthCare's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .